Alkermes (NasdaqGS:ALKS) FY Conference Transcript

Alkermes (NasdaqGS:ALKS) FY Conference January 13, 2026 01:30 PM ET Company ParticipantsRichard Pops - CEOConference Call ParticipantsNone - AnalystJessica Fye - Managing Director and Senior Biotechnology AnalystJessica FyeGreat. Welcome, everyone. My name's Jess Fye. I'm a biotech analyst at J.P. Morgan, and we're continuing the 44th Annual Healthcare Conference today with Alkermes. We're going to hear a presentation from the management team, and then we're going to go into some Q&A. Because of J.P. Morgan ...